BillionToOne to Participate in the 44th Annual J.P. Morgan Healthcare Conference | BLLN Stock News
I'm PortAI, I can summarize articles.
BillionToOne, Inc. (NASDAQ: BLLN), a molecular diagnostics company, will participate in the 44th Annual J.P. Morgan Healthcare Conference. The company's management will present on January 12th, 2026. A live and archived webcast will be available on their investor relations website. BillionToOne is known for its Quantitative Counting Templates™ (QCT™) technology, which accurately counts DNA molecules at the single-molecule level.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: StockTitan The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments